Notably, HOXD10 is expressed at low levels in ESCC tissues and cell lines, while its overexpression has the potential to activate malignant phenotypes of ESCC cells through the inhibition of the PI3K/AKT/mTOR signaling pathway. The gene discussed is MTOR; the disease is esophageal squamous cell carcinoma.